SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001358403-19-000123
Filing Date
2019-11-06
Accepted
2019-11-06 17:00:31
Documents
79
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a2019q310q.htm 10-Q 1455017
2 EXHIBIT 31.1 exh3112019q3.htm EX-31.1 13923
3 EXHIBIT 31.2 exh3122019q3.htm EX-31.2 14132
4 EXHIBIT 32.1 exh3212019q3.htm EX-32.1 12591
  Complete submission text file 0001358403-19-000123.txt   6768901

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT blcm-20190930.xml EX-101.INS 1280360
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20190930.xsd EX-101.SCH 45229
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blcm-20190930_cal.xml EX-101.CAL 94631
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20190930_def.xml EX-101.DEF 269196
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20190930_lab.xml EX-101.LAB 656235
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20190930_pre.xml EX-101.PRE 419308
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36783 | Film No.: 191197087
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences